Citations (108)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Suresh Thanjavur Mani, Thirumalaisamy Rathinavel, Subramanian Ammashi & Muhammad Nasir Iqbal. (2023) Polycyclic Aromatic Bioactive Compounds from Eclipta Alba and Its Anticancer Potential against Breast Cancer Target Proteins: An Antibreast Cancer Intervention through In Silico and In Vitro Validations. Polycyclic Aromatic Compounds 0:0, pages 1-30.
Read now
Read now
Jules M. Elias, Dan M. Hyder, Richard J. Miksicek, Alan Heimann & Michele Margiotta. (1995) Interpretation of Steroid Receptors in Breast Cancer. A Case With Discordant Estrogen Receptor Results Using ER1D5 and H222 Antibodies. Journal of Histotechnology 18:4, pages 331-335.
Read now
Read now
Henrik C. J. Nyholm, Anette L. Nielsen, Jens Lyndrup & Susan M. Thorpe. (1993) Progesterone receptor content in endometrial carcinoma correlates with serum levels of free estradiol. Acta Obstetricia et Gynecologica Scandinavica 72:7, pages 565-569.
Read now
Read now
Olle Stål, Ann Brisfors, John Carstensen, Lilianne Ferraud & Thomas Hatschek. (1992) Interrelations Between Cellular DNA Content, S-Phase Fraction, Hormone Receptor Status and Age in Primary Breast Cancer A Series of 1 342 Consecutively Detected Tumors. Acta Oncologica 31:3, pages 283-292.
Read now
Read now
Mirjana V. Branković-Magić, Dragica B. Nikolić-Vukosavljevic`, Zora B. Nešković-Konstantinović, Ksenija S. Kanjer & Ivan V. Spužić. (1992) Variations in the Content of Steroid Receptors in Breast Cancer: Comparison between primary tumors and metastatic lesions. Acta Oncologica 31:6, pages 629-633.
Read now
Read now
Jørn Andersen. (1992) Determination of Estrogen Receptors in Paraffin-Embedded Tissue: Techniques and the value in breast cancer treatment. Acta Oncologica 31:6, pages 611-627.
Read now
Read now
O. Mathiesen, O. Bonderup, J. Carl, J. Panduro & K. O. Pedersen. (1991) The Prognostic Value of Estrogen and Progesterone Receptors in Female Breast Cancer. A Single Center Study. Acta Oncologica 30:6, pages 691-695.
Read now
Read now
M. Fernö, Å. Borg, U. Johansson, A. Norgren, H. Olsson, S. Rydén & G. Sellberg. (1990) Estrogen and Progesterone Receptor Analyses in More Than 4000 Human Breast Cancer Samples: A Study with Special Reference to Age at diagnosis and stability of analyses. Acta Oncologica 29:2, pages 129-135.
Read now
Read now
O. Mathiesen, J. Carl, O. Bonderup & J. Panduro. (1990) Axillary Sampling and the Risk of Erroneous Staging of Breast Cancer: An analysis of 960 consecutive patients. Acta Oncologica 29:6, pages 721-725.
Read now
Read now
B. Nordenskjöld. (1990) Endocrine Therapy of Breast Cancer: A background. Acta Oncologica 29:3, pages 367-369.
Read now
Read now
Articles from other publishers (98)
Jéssica Borghesi, Sara Caceres, Lara Carolina Mario, Angela Alonso-Diez, Ana Carolina Silveira Rabelo, Maria J. Illera, Gema Silvan, Maria Angélica Miglino, Phelipe O. Favaron, Ana Claudia O. Carreira & Juan Carlos Illera. (2020) Effects of doxorubicin associated with amniotic membrane stem cells in the treatment of canine inflammatory breast carcinoma (IPC-366) cells. BMC Veterinary Research 16:1.
Crossref
Crossref
Dewmini Mututantri-Bastiyange & James C. L. Chow. (2020) Imaging dose of cone-beam computed tomography in nanoparticle-enhanced image-guided radiotherapy: A Monte Carlo phantom study. AIMS Bioengineering 7:1, pages 1-11.
Crossref
Crossref
Genevieve Dall, Gail Risbridger & Kara Britt. (2017) Mammary stem cells and parity-induced breast cancer protection- new insights. The Journal of Steroid Biochemistry and Molecular Biology 170, pages 54-60.
Crossref
Crossref
Mohammadhossein Hajiebrahimi, Scott Montgomery, Sarah Burkill & Shahram Bahmanyar. (2016) Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients. PLOS ONE 11:10, pages e0165027.
Crossref
Crossref
Lei Zhong, Kuixi Zhu, Nana Jin, Deng Wu, Jianguo Zhang, Baoliang Guo, Zhaoqi Yan & Qingyuan Zhang. (2014) A Systematic Analysis of miRNA-mRNA Paired Variations Reveals Widespread miRNA Misregulation in Breast Cancer. BioMed Research International 2014, pages 1-8.
Crossref
Crossref
Navneet Singh, Moltira Promkan, Guangming Liu, James Varani & Subhas Chakrabarty. (2013) Role of Calcium sensing receptor (CaSR) in tumorigenesis. Best Practice & Research Clinical Endocrinology & Metabolism 27:3, pages 455-463.
Crossref
Crossref
Yuriy GusevRebecca B. RigginsKrithika BhuvaneshwarRobinder GaubaLaura SheahanRobert ClarkeSubha Madhavan. (2013) In Silico Discovery of Mitosis Regulation Networks Associated with Early Distant Metastases in Estrogen Receptor Positive Breast Cancers. Cancer Informatics 12, pages CIN.S10329.
Crossref
Crossref
E. Uriol, M. Sierra, M. A. Comendador, J. Fra, P. Mart?nez-Camblor, A. J. Lacave & L. M. Sierra. (2013) Long-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictive factor. Mutagenesis 28:1, pages 39-48.
Crossref
Crossref
Mohammad Hossein Hajiebrahimi, Shahram Bahmanyar, Mats Lambe, Jan Adolfsson, Tommy Fornander, Fredrik Wärnberg & Sven Cnattingius. (2012) Placental weight and mortality in premenopausal breast cancer by tumor characteristics. Breast Cancer Research and Treatment 137:1, pages 297-305.
Crossref
Crossref
Frederick G Strathmann, Grace Borlee, Donald E Born, Luis F Gonzalez-Cuyar, Bertrand R Huber & Geoffrey S Baird. (2012) Multiplex Immunoassays of Peptide Hormones Extracted from Formalin-Fixed, Paraffin-Embedded Tissue Accurately Subclassify Pituitary Adenomas. Clinical Chemistry 58:2, pages 366-374.
Crossref
Crossref
Antonella Muscella, Nadia Calabriso, Carla Vetrugno, Francesco Paolo Fanizzi, Sandra Angelica De Pascali, Carlo Storelli & Santo Marsigliante. (2011) The platinum (II) complex [Pt(O,O′-acac)(γ-acac)(DMS)] alters the intracellular calcium homeostasis in MCF-7 breast cancer cells. Biochemical Pharmacology 81:1, pages 91-103.
Crossref
Crossref
José M.A. Moreira, Teresa Cabezón, Irina Gromova, Pavel Gromov, Vera Timmermans-Wielenga, Isidro Machado, Antonio Llombart-Bosch, Niels Kroman, Fritz Rank & Julio E. Celis. (2010) Tissue proteomics of the human mammary gland: Towards an abridged definition of the molecular phenotypes underlying epithelial normalcy. Molecular Oncology 4:6, pages 539-561.
Crossref
Crossref
Sunil R Lakhani, Kum Kum Khanna & Georgia Chenevix-Trench. (2010) Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?. Breast Cancer Research 12:2.
Crossref
Crossref
Robert Clarke, Ayesha N. Shajahan, Rebecca B. Riggins, Younsook Cho, Anatasha Crawford, Jianhua Xuan, Yue Wang, Alan Zwart, Ruchi Nehra & Minetta C. Liu. (2009) Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 114:1-2, pages 8-20.
Crossref
Crossref
Guangming Liu, Xin Hu & Subhas Chakrabarty. (2009) Calcium sensing receptor down-regulates malignant cell behavior and promotes chemosensitivity in human breast cancer cells. Cell Calcium 45:3, pages 216-225.
Crossref
Crossref
K.L. Cheung. (2007) Endocrine therapy for breast cancer: an overview. The Breast 16:4, pages 327-343.
Crossref
Crossref
Ke-Da Yu, Guang-Yu Liu, Gen-Hong Di, Jiong Wu, Jin-Song Lu, Kun-Wei Shen, Zhen-Zhou Shen & Zhi-Ming Shao. (2007) Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients. The Breast 16:3, pages 307-315.
Crossref
Crossref
Swann Arp Adams, Charles E. Matthews, James R. Hebert, Charity G. Moore, Joan E. Cunningham, Xiou-Oi Shu, Jeanette Fulton, Yutang Gao & Wei Zheng. (2006) Association of Physical Activity with Hormone Receptor Status: The Shanghai Breast Cancer Study. Cancer Epidemiology, Biomarkers & Prevention 15:6, pages 1170-1178.
Crossref
Crossref
Reiko Suzuki, Weimin Ye, Tove Rylander-Rudqvist, Shigehira Saji, Graham A. Colditz & Alicja Wolk. (2005) Alcohol and Postmenopausal Breast Cancer Risk Defined by Estrogen and Progesterone Receptor Status: A Prospective Cohort Study. JNCI: Journal of the National Cancer Institute 97:21, pages 1601-1608.
Crossref
Crossref
Cristina Riva, Emanuele Dainese, Giacomo Caprara, Paolo Cossu Rocca, Giovanni Massarelli, Tibor Tot, Carlo Capella & Vincenzo Eusebi. (2005) Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma. Virchows Archiv 447:4, pages 695-700.
Crossref
Crossref
Shumin M. Zhang, Susan E. Hankinson, David J. Hunter, Edward L. Giovannucci, Graham A. Colditz & Walter C. Willett. (2005) Folate Intake and Risk of Breast Cancer Characterized by Hormone Receptor Status. Cancer Epidemiology, Biomarkers & Prevention 14:8, pages 2004-2008.
Crossref
Crossref
Marilena Lanzino, Francesca De Amicis, Michael J. McPhaul, Stefania Marsico, Maria Luisa Panno & Sebastiano Andò. (2005) Endogenous Coactivator ARA70 Interacts with Estrogen Receptor α (ERα) and Modulates the Functional ERα/Androgen Receptor Interplay in MCF-7 Cells. Journal of Biological Chemistry 280:21, pages 20421-20430.
Crossref
Crossref
Vijay L. Kumar, Anurag Srivastava, Rohit Singhal & Vijay Kumar. (2005) Immunoreactive estrogen receptor in breast tumor and adjacent tissue: Association with clinicopathological characteristics in Indian population. Journal of Surgical Oncology 89:4, pages 251-255.
Crossref
Crossref
M. P. G. Leers, J. G. M. Hoop, M. van Beers, N. van Rodijnen, M. Pannebakker & M. Nap. (2005) Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas. Cytometry Part B: Clinical Cytometry 64B:1, pages 43-52.
Crossref
Crossref
Jill A. McDonald, Michele G. Mandel, Polly A. Marchbanks, Suzanne G. Folger, Janet R. Daling, Giske Ursin, Michael S. Simon, Leslie Bernstein, Brian L. Strom, Sandra A. Norman, Kathleen E. Malone, Linda K. Weiss, Ronald T. Burkman, Anita L. Weber & Robert Spirtas. (2004) Alcohol Exposure and Breast Cancer: Results of the Women's Contraceptive and Reproductive Experiences Study. Cancer Epidemiology, Biomarkers & Prevention 13:12, pages 2106-2116.
Crossref
Crossref
Bieke Van Den Bossche & Christophe Van de Wiele. (2004) Receptor Imaging in Oncology by Means of Nuclear Medicine: Current Status. Journal of Clinical Oncology 22:17, pages 3593-3607.
Crossref
Crossref
W. D. Foulkes. (2004) Re: Estrogen Receptor Status of Primary Breast Cancer Is Predictive of Estrogen Receptor Status of Contralateral Breast Cancer. JNCI Journal of the National Cancer Institute 96:13, pages 1040-1041.
Crossref
Crossref
Cecilie T Freddie, Søren S Larsen, Monica Bartholomæussen & Anne E Lykkesfeldt. (2004) The effect of the new SERM arzoxifene on growth and gene expression in MCF-7 breast cancer cells. Molecular and Cellular Endocrinology 219:1-2, pages 27-36.
Crossref
Crossref
William D. Foulkes, Kelly Metcalfe, Ping Sun, Wedad M. Hanna, Henry T. Lynch, Parviz Ghadirian, Nadine Tung, Olufunmilayo I. Olopade, Barbara L. Weber, Jane McLennan, Ivo A. Olivotto, Louis R. Bégin & Steven A. Narod. (2004)
Estrogen Receptor Status in
BRCA1
- and
BRCA2
-Related Breast Cancer
. Clinical Cancer Research 10:6, pages 2029-2034.
Crossref
Crossref
Shumin M Zhang. (2004) Role of vitamins in the risk, prevention, and treatment of breast cancer. Current Opinion in Obstetrics and Gynecology 16:1, pages 19-25.
Crossref
Crossref
M R E McCredie, G S Dite, M C Southey, D J Venter, G G Giles & J L Hopper. (2003) Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status. British Journal of Cancer 89:9, pages 1661-1663.
Crossref
Crossref
Alessandro Morabito, Elena Magnani, Massimo Gion, Roberta Sarmiento, Barbara Capaccetti, Raffaele Longo, Domenico Gattuso & Giampietro Gasparini. (2003) Prognostic and Predictive Indicators in Operable Breast Cancer. Clinical Breast Cancer 3:6, pages 381-390.
Crossref
Crossref
N Honma, G Sakamoto, F Akiyama, Y Esaki, M Sawabe, T Arai, T Hosoi, N Harada, M Younes & K Takubo. (2003) Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor status. Histopathology 42:2, pages 120-127.
Crossref
Crossref
G. Konecny, G. Pauletti, M. Pegram, M. Untch, S. Dandekar, Z. Aguilar, C. Wilson, H.-M. Rong, I. Bauerfeind, M. Felber, H.-J. Wang, M. Beryt, R. Seshadri, H. Hepp & D. J. Slamon. (2003) Quantitative Association Between HER-2/neu and Steroid Hormone Receptors in Hormone Receptor-Positive Primary Breast Cancer. JNCI Journal of the National Cancer Institute 95:2, pages 142-153.
Crossref
Crossref
D. Nikolic-Vukosavljevic, K. Kanjer, Z. Neskovic-Konstantinovic & D. Vukotic. (2018) Natural History of Estrogen Receptor-Negative, Progesterone Receptor-Positive Breast Cancer. The International Journal of Biological Markers 17:3, pages 196-200.
Crossref
Crossref
S Andò, F De Amicis, V Rago, A Carpino, M Maggiolini, M.L Panno & M Lanzino. (2002) Breast cancer: from estrogen to androgen receptor. Molecular and Cellular Endocrinology 193:1-2, pages 121-128.
Crossref
Crossref
Indra Poola, Robert Clarke, Robert DeWitty & LaSelle D. Leffall. (2002) Functionally active estrogen receptor isoform profiles in the breast tumors of African American women are different from the profiles in breast tumors of Caucasian women. Cancer 94:3, pages 615-623.
Crossref
Crossref
J.P. Brouillet, M.A. Dujardin, D. Chalbos, J.M. Rey, J. Grenier, P.J. Lamy, T. Maudelonde & P. Pujol. (2001) Analysis of the potential contribution of estrogen receptor (ER) ? in ER cytosolic assay of breast cancer. International Journal of Cancer 95:4, pages 205-208.
Crossref
Crossref
Kenneth C. Chu, William F. Anderson, April Fritz, Lynn A. G. Ries & Otis W. Brawley. (2001) Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer 92:1, pages 37-45.
Crossref
Crossref
Keun-Young Yoo, Kazuo Tajima, Sue-Kyung Park, Daehee Kang, Sook-Un Kim, Kaoru Hirose, Tohru Takeuchi & Shigeto Miura. (2001) Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan). Cancer Letters 167:1, pages 57-63.
Crossref
Crossref
K.L. Cheung & J.F.R. Robertson. (2001) Preoperative hormone therapy trials for breast cancer. The Breast 10:1, pages 1-5.
Crossref
Crossref
William F. AndersonKenneth C. ChuNilanjan ChatterjeeOtis BrawleyLouise A. Brinton. (2001) Tumor Variants by Hormone Receptor Expression in White Patients With Node-Negative Breast Cancer From the Surveillance, Epidemiology, and End Results Database. Journal of Clinical Oncology 19:1, pages 18-27.
Crossref
Crossref
T. Cooke, J. Reeves, A. Lanigan & P. Stanton. (2001) HER2 as a prognostic and predictive marker for breast cancer. Annals of Oncology 12, pages S23-S28.
Crossref
Crossref
T. Cooke, J. Reeves, A. Lannigan & P. Stanton. (2001) The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker. European Journal of Cancer 37, pages 3-10.
Crossref
Crossref
Louis W.C. Chow & Pei Ho. (2000) Hormonal receptor determination of 1,052 Chinese breast cancers. Journal of Surgical Oncology 75:3, pages 172-175.
Crossref
Crossref
Kerstin Struse, Werner Audretsch, Mahdi Rezai, Guido Pott & Hans Bojar. (2000) The Estrogen Receptor Paradox in Breast Cancer: Association of High Receptor Concentrations with Reduced Overall Survival. The Breast Journal 6:2, pages 115-125.
Crossref
Crossref
Massimo Gion, Patrizia Boracchi, Ruggero Dittadi, Elia Biganzoli, Lucia Peloso, Carlo Gatti, Adriano Paccagnella, Alberto Rosabian, Orazio Vinante & Sabrina Meo. (2000) Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosis. Breast Cancer Research and Treatment 59:3, pages 211-221.
Crossref
Crossref
Matthias Fippel, Wolfram Laub, Bernd Huber & Fridtjof Nüsslin. (1999) Experimental investigation of a fast Monte Carlo photon beam dose calculation algorithm. Physics in Medicine and Biology 44:12, pages 3039-3054.
Crossref
Crossref
A. E. Pinto, S. Andre & J. Soares. (1999) Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients. Journal of Clinical Pathology 52:8, pages 604-611.
Crossref
Crossref
Jacqueline Ashba & Abdulmaged M. Traish. (1999) Estrogen and Progesterone Receptor Concentrations and Prevalence of Tumor Hormonal Phenotypes in Older Breast Cancer Patients. Cancer Detection <html_ent glyph="@amp;" ascii="&"/> Prevention 23:3, pages 238-244.
Crossref
Crossref
Jan Wohlfahrt, Henning Mouridsen, Per Kragh Andersen & Mads Melbye. (1999) Reproductive risk factors for breast cancer by receptor status, histology, laterality and location. International Journal of Cancer 81:1, pages 49-55.
Crossref
Crossref
R L Balleine, M J Earl, M L Greenberg & C L Clarke. (1999) Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women. British Journal of Cancer 79:9-10, pages 1564-1571.
Crossref
Crossref
S M Enger, R K Ross, A Paganini-Hill, M P Longnecker & L Bernstein. (1999) Alcohol consumption and breast cancer oestrogen and progesterone receptor status. British Journal of Cancer 79:7-8, pages 1308-1314.
Crossref
Crossref
Leonie J.M Rijks, Jan C van den Bos, Peter A.P.M van Doremalen, Gerard J Boer, Kora de Bruin, Anton G.M Janssen & Eric A van Royen. (1998) New iodinated progestins as potential ligands for progesterone receptor imaging in breast cancer. part 2: in vivo pharmacological characterization. Nuclear Medicine and Biology 25:8, pages 791-798.
Crossref
Crossref
Pascal Pujol, Jean-Pierre Daures, Simon Thezenas, Fan�oise Guilleux, Phillipe Rouanet & Jean Grenier. (1998) Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause. Cancer 83:4, pages 698-705.
Crossref
Crossref
R. Dittadi, E. Biganzoli, P. Boracchi, C. Salbe, R. Mione, C. Gatti & M. Gion. (2018) Impact of Steroid Receptors, pS2 and Cathepsin D on the Outcome of N+ Postmenopausal Breast Cancer Patients Treated with Tamoxifen. The International Journal of Biological Markers 13:1, pages 30-41.
Crossref
Crossref
Max Görlich & Burkhard Jandrig. (2018) Steroid Hormone Receptors Related to Parameters Characterizing the Biology of Human Breast Cancer. Tumori Journal 83:6, pages 930-937.
Crossref
Crossref
A. Makris, D.C. Allred, T.J. Powles, M. Dowsett, I.N. Fernando, P.A. Trott, S.E. Ashley, M.G. Ormerod, J.C. Titley & C.K. Osborne. (1997) Cytological evaluation of biological prognostic markers from primary breast carcinomas. Breast Cancer Research and Treatment 44:1, pages 65-74.
Crossref
Crossref
Andrew W. Scribner, Serkos A. Haroutounian, Kathryn E. Carlson & John A. Katzenellenbogen. (1997) 1-Aryl-2-pyridyl-3,4-dihydronaphthalenes: Photofluorogenic Ligands for the Estrogen Receptor. The Journal of Organic Chemistry 62:4, pages 1043-1057.
Crossref
Crossref
Julie A. Ross, Richard K. Severson, Scott Davis, Janet L. Stanford & John D. Potter. (1997) Seasonal trends in the self-detection of breast cancer: indications from the Cancer and Steroid Hormone (CASH) study. Breast Cancer Research and Treatment 42:2, pages 187-192.
Crossref
Crossref
S Romain, F Spyratos, J Goussard, JL Formento & H Magdelénat. (1997) Amélioration du contrôle de qualité pour les dosages de récepteurs stéroïdiens: analyse des distributions dans plus de 40 000 cancers primitifs du sein. Immuno-analyse & Biologie Spécialisée 12:1, pages 21-23.
Crossref
Crossref
HENRIK CHRISTIAN JUUL NYHOLM. (2011) Estrogen and progesterone receptors in endometrial cancer Clinicopathological correlations and prognostic significance. APMIS 104:S65, pages 5-33.
Crossref
Crossref
V. Kuenen-Boumeester, T.H. Van der Kwast, C.C. Claassen, M.P. Look, G.S. Liem, J.G.M. Klijn & S.C. Henzen-Logmans. (1996) The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters. European Journal of Cancer 32:9, pages 1560-1565.
Crossref
Crossref
Sylvie Romain, Frédérique Spyratos, Jacques Goussard, Jean-Louis Formento & Henri Magdelénat. (1996) Improvement of quality control for steroid receptor measurements: Analysis of distributions in more than 40000 primary breast cancers. Breast Cancer Research and Treatment 41:2, pages 131-139.
Crossref
Crossref
Sue A. Joslyn, Dean H. Gesme & Charles F. Lynch. (1996) Estrogen and Progesterone Receptors in Primary Breast Cancer. The Breast Journal 2:3, pages 187-196.
Crossref
Crossref
Susan M. Gapstur, Josée Dupuis, Peter Gann, Susan Collila & David P. Winchester. (1996) Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic white women: An analysis of 13,239 cases. Cancer 77:8, pages 1465-1471.
Crossref
Crossref
M. L. Wallace & B. R. Smoller. (2006) Progesterone receptor positivity supports hormonal control of syringomas. Journal of Cutaneous Pathology 22:5, pages 442-445.
Crossref
Crossref
Serkos A. Haroutounian, Andrew W. Scribner & John A. Katzenellenbogen. (1995) Derivatives of 4-styrylpyridines: Synthesis, estrogen receptor binding affinity, and photophysical properties. Steroids 60:9, pages 636-645.
Crossref
Crossref
Steven T. Brower, Sharmila Ahmed, Paul I. Tartter, Ira Bleiweiss & J. B. Amberson. (1995) Prognostic variables in invasive breast cancer: Contribution of comedo versus noncomedo in situ component. Annals of Surgical Oncology 2:5, pages 440-444.
Crossref
Crossref
Stephanie E. Weiss, Paul I. Tartter, Sharmila Ahmed, Steven T. Brower, Cristina Brusco, Kathy Bossolt, James B. Amberson & Joan Bratton. (1995) Ethnic differences in risk and prognostic factors for breast cancer. Cancer 76:2, pages 268-274.
Crossref
Crossref
Yearn Seong Choe, Thomas A. Bonasera, Dae Yoon Chi, Michael J. Welch & John A. Katzenellenbogen. (1995) 6?-[18F]Fluoroprogesterone: Synthesis via halofluorination-oxidation, receptor binding and tissue distribution. Nuclear Medicine and Biology 22:5, pages 635-642.
Crossref
Crossref
Serkos A. Haroutounian & John A. Katzenellenbogen. (1995) 4?-Hydroxystyryldiazines: Synthesis and fluorescence properties. Tetrahedron 51:6, pages 1585-1598.
Crossref
Crossref
S. Romain, C. Laine Bidron, P.M. Martin, H. Magdelenat, J.A. Foekens, L. Skoog, B. Nordenskjold, M. Fernö & J.P. Peyrat. (1995) steroid receptor distribution in 47 892 breast cancers. A collaborative study of 7 European laboratories. European Journal of Cancer 31:3, pages 411-417.
Crossref
Crossref
Jeffrey D. Seidman, Lauren A. Schnaper & Seena C. Aisner. (1995) Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastasis. Cancer 75:1, pages 65-71.
Crossref
Crossref
Catherine Schairer, Celia Byrne, Penelope M. Keyl, Louise A. Brinton, Susan R. Sturgeon & Robert N. Hoover. (1994) Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States). Cancer Causes & Control 5:6, pages 491-500.
Crossref
Crossref
Emi Odagiri, Naotoshi Kanda, Kazuko Jibiki, Reiko Demura, Eizou Aikawa & Hiroshi Demura. (1994) Reduction of telomeric length and c-erbb-2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters. Cancer 73:12, pages 2978-2984.
Crossref
Crossref
Vibeke Ravn, Birgitte Bruun Rasmussen, Lone H�jholt, Marianne Barfoed, Inger Heiberg, Birgit Svenstrup & Susan M. Thorpe. (1994) Estrogen- and progesterone receptors in normal cycling endometrium as studied by end-point titration. Cell & Tissue Research 276:3, pages 419-428.
Crossref
Crossref
Shahla Masood. (2006) Prognostic and diagnostic implications of estrogen and progesterone receptor assays in cytology. Diagnostic Cytopathology 10:3, pages 263-267.
Crossref
Crossref
Paul T Pearce, Kathy M Myles & John W Funder. (1993) Oestrogen and progesterone receptor assays in breast tumours. Medical Journal of Australia 159:4, pages 227-231.
Crossref
Crossref
Greorgy M. Anstead, Kwang‐Jin Hwang & John A. Katzenellenbogen. (2008) CHARACTERIZATION OF THE SPECTROSCOPIC PROPERTIES OF A TETRAHYDROCHRYSENE SYSTEM CONTAINING A RIGIDIFIED HYDROXYNITROSTILBENE CHROMOPHORE: AN INHERENTLY FLUORESCENT LIGAND DESIGNED FOR THE ESTROGEN RECEPTOR. Photochemistry and Photobiology 57:4, pages 616-628.
Crossref
Crossref
S.M. Thorpe, I.J. Christensen, B.B. Rasmussen & C. Rose. (1993) Short recurrence-free survival associated with high oestrogen receptor levels in the natural history of postmenopausal, primary breast cancer. European Journal of Cancer 29:7, pages 971-977.
Crossref
Crossref
Andrew N. French, Elio Napolitano, Henry F. Vanbrocklin, Robert N. Hanson, Michael J. Welch & John A. Katzenellenbogen. (1993) Synthesis, radiolabeling and tissue distribution of 11?-fluoroalkyl- and 11?-fluoroalkoxy-substituted estrogens: Target tissue uptake selectivity and defluorination of a homologous series of fluorine-18-labeled estrogens. Nuclear Medicine and Biology 20:1, pages 31-47.
Crossref
Crossref
Massimo Gion, Riccardo Mione, Giovanni L. Pappagallo, Carlo Gatti, Ottorino Nascimben, Alba Brandes, Orazio Vinante & Giuliano Bruscagnin. (1993) Tissue polypeptide antigen in breast cancer cytosol: a new effective prognostic indicator. European Journal of Cancer 29:1, pages 66-69.
Crossref
Crossref
S. Chadha, B.R. Rao, B.J. Slotman, C.C.J. van Vroonhoven & Th.H. van der Kwast. (1993) An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors. Human Pathology 24:1, pages 90-95.
Crossref
Crossref
Kwang Jin Hwang, Kathryn E. Carlson, Gregory M. Anstead & John A. Katzenellenbogen. (2002) Donor-acceptor tetrahydrochrysenes, inherently fluorescent, high-affinity ligands for the estrogen receptor: binding and fluorescence characteristics and fluorometric assay of receptor. Biochemistry 31:46, pages 11536-11545.
Crossref
Crossref
V. Kuenen‐Boumeester, Th. H. van der Kwast, W. L. J. van Putten, C. Claassen, B. van Ooijen & S. C. Henzen‐Logmans. (2006) Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer. International Journal of Cancer 52:4, pages 581-584.
Crossref
Crossref
Shahla Masood. (2007) Estrogen and progesterone receptors in cytology: A comprehensive review. Diagnostic Cytopathology 8:5, pages 475-491.
Crossref
Crossref
Giampietro Gasparini, Franco Pozza, Ruggero Dittadi, Salvatore Meli, Stefania Cazzavillan & Pierantonio Bevilacqua. (1992) Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancer. Journal of Cancer Research and Clinical Oncology 118:7, pages 557-563.
Crossref
Crossref
Olle Stål, Ann Brisfors, John Carstensen, Lilianne Ferraud, Thomas Hatschek & Bo Nordenskjöld. (2006) Relationships of DNA ploidy, S‐phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. International Journal of Cancer 51:1, pages 28-33.
Crossref
Crossref
Shahla Masood. 1992. Serological Cancer Markers. Serological Cancer Markers
151
192
.
Stjepan Gamulin & Ranka Romić-Stojković. (1991) Oestrogen and progesterone receptors in primary breast cancer: a population study. European Journal of Cancer and Clinical Oncology 27:4, pages 491-495.
Crossref
Crossref
R. Valavaara, J. Tuominen & R. Johansson. (1990) Predictive value of tumor estrogen and progesterone receptor levels in postmenopausal women with advanced breast cancer treated with toremifene. Cancer 66:11, pages 2264-2269.
Crossref
Crossref
P.N. COWEN, J. TEASDALE, P. JACKSON & B.J. REID. (2007) Oestrogen receptor in breast cancer: prognostic studies using a new immunohistochemical assay. Histopathology 17:4, pages 319-325.
Crossref
Crossref
James A. Robb. (1990) The future anatomic pathology laboratory for molecular diagnosis and prognosis: Circa 1990?95. Clinical Biochemistry 23:4, pages 295-299.
Crossref
Crossref
Jørn Andersen, Susan M. Thorpe, William J. King, Carsten Rose, Ib Christensen, Birgitte B. Rasmussen & Hans S. Poulsen. (1990) The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays. European Journal of Cancer and Clinical Oncology 26:4, pages 442-449.
Crossref
Crossref
Martin G. Pomper, Kevin G. Pinney, Kathryn E. Carlson, Henry Van Brocklin, Carla J. Mathias, Michael J. Welch & John A. Katzenellenbogen. (1990) Target tissue uptake selectivity of three fluorine-substituted progestins: Potential imaging agents for receptor-positive breast tumors. International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology 17:3, pages 309-319.
Crossref
Crossref
M. Helle, M. Helin, J. Isola & H. Helin. (1989) Immunohistochemical versus biochemical estrogen-receptor and progesterone-receptor analysis: correlation with histological parameters. Journal of Cancer Research and Clinical Oncology 115:4, pages 361-365.
Crossref
Crossref
ARE HELSETH, SVERRE J. MØRK, AAGE JOHANSEN & STEINAR TRETLI. (1989) Neoplasms of the central nervous system in Norway. APMIS 97:7-12, pages 646-654.
Crossref
Crossref